SIPA1 promotes angiogenesis by regulating VEGF secretion in Müller cells through STAT3 activation

Area of Science:

• Ophthalmology
• Diabetology
• Cell Biology

Background:

• Diabetic retinopathy (DR) is a leading cause of vision loss due to diabetes-induced retinal microvasculature damage.
• Müller cells are critical in regulating the retinal vascular microenvironment.
• Chronic hyperglycemia in diabetes exacerbates retinal damage.

Purpose of the Study:

• To investigate the role of signal-induced proliferation-associated protein 1 (SIPA1) in Müller cell-mediated angiogenesis.
• To elucidate the molecular mechanisms by which SIPA1 influences retinal vascularization in the context of diabetes.

Main Methods:

• Proteomics and database analysis to identify SIPA1 expression changes.
• Endothelial cell function assays to assess vascular effects.
• Western blot and STAT3 inhibition (STATTIC) to study signaling pathways.

Main Results:

• SIPA1 expression is upregulated in Müller cells under high glucose conditions.
• SIPA1 promotes vascular endothelial growth factor (VEGF) secretion and retinal vascular endothelial cell migration.
• SIPA1 activates STAT3 phosphorylation and nuclear translocation, mediating VEGF expression.

Conclusions:

• SIPA1 promotes pro-angiogenic factor secretion in Müller cells by activating the STAT3 signaling pathway.
• SIPA1 plays a significant role in the pathogenesis of diabetic retinopathy.
• SIPA1 represents a potential therapeutic target for managing diabetic retinopathy.